- PIPERIDINYL COMPOUNDS THAT SELECTIVELY BIND INTEGRINS
-
The invention is directed to piperidinyl compounds of formula (I) and (II) that selectively bind integrin receptors and methods for treating an integrin mediated disorder, wherein W, R2, Z and q are described in the application.
- -
-
-
- Nonpeptide αvβ3 antagonists. Part 2: Constrained glycyl amides derived from the RGD tripeptide
-
Mimetics of the RGD tripeptide are described that are potent, selective antagonists of the integrin receptor, αvβ3. The use of the 5,6,7,8-tetrahydro[1,8]naphthyridine group as a potency-enhancing N-terminus is demonstrated. Two 3-substituted-3-amino-propionic acids previously contained in αIIbβ3 antagonists were utilized to enhance binding affinity and functional activity for the targeted receptor. Further affinity increases were then achieved through the use of cyclic glycyl amide bond constraints.
- Meissner, Robert S.,Perkins, James J.,Duong, Le T.,Hartman, George D.,Hoffman, William F.,Huff, Joel R.,Ihle, Nathan C.,Leu, Chih-Tai,Nagy, Rose M.,Naylor-Olsen, Adel,Rodan, Gideon A.,Rodan, Sevgi B.,Whitman, David B.,Wesolowski, Gregg A.,Duggan, Mark E.
-
-
